BTLA: a new inhibitory receptor with a B7-like ligand
Copyright policy )BTLA: a new inhibitory receptor with a B7-like ligand
The B and T lymphocyte attenuator, BTLA, is a recently discovered Ig superfamily member. BTLA engagement results in downregulation of T-cell activation, and mice deficient in BTLA show increased incidence and severity of autoimmune disorders. A novel B7 family member, B7x (B7S1, B7-H4), has been proposed as the ligand for BTLA. A B7x-Ig fusion protein inhibits T-cell activation and interleukin-2 (IL-2) production. Thus, cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death-1 (PD-1) and BTLA comprise an expanding set of inhibitory receptors expressed on lymphocytes.
B-Lymphocytes, Genes, Immunoglobulin, T-Lymphocytes, Receptors, Antigen, T-Cell, V-Set Domain-Containing T-Cell Activation Inhibitor 1, Ligands, Lymphocyte Activation, B7-1 Antigen, Animals, Humans, Receptors, Immunologic, Signal Transduction
B-Lymphocytes, Genes, Immunoglobulin, T-Lymphocytes, Receptors, Antigen, T-Cell, V-Set Domain-Containing T-Cell Activation Inhibitor 1, Ligands, Lymphocyte Activation, B7-1 Antigen, Animals, Humans, Receptors, Immunologic, Signal Transduction
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).88 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!